Firefly Neuroscience (AIFF) Common Equity (2016 - 2025)
Historic Common Equity for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $9.7 million.
- Firefly Neuroscience's Common Equity rose 44800.0% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 44800.0%. This contributed to the annual value of -$375000.0 for FY2024, which is 44403.67% down from last year.
- Latest data reveals that Firefly Neuroscience reported Common Equity of $9.7 million as of Q3 2025, which was up 44800.0% from $12.1 million recorded in Q2 2025.
- In the past 5 years, Firefly Neuroscience's Common Equity registered a high of $17.4 million during Q4 2021, and its lowest value of -$2.8 million during Q3 2024.
- For the 5-year period, Firefly Neuroscience's Common Equity averaged around $5.0 million, with its median value being $2.6 million (2023).
- As far as peak fluctuations go, Firefly Neuroscience's Common Equity plummeted by 44403.67% in 2024, and later surged by 5771111.11% in 2025.
- Over the past 5 years, Firefly Neuroscience's Common Equity (Quarter) stood at $17.4 million in 2021, then plummeted by 112.76% to -$2.2 million in 2022, then skyrocketed by 104.9% to $109000.0 in 2023, then tumbled by 444.04% to -$375000.0 in 2024, then soared by 2675.2% to $9.7 million in 2025.
- Its Common Equity was $9.7 million in Q3 2025, compared to $12.1 million in Q2 2025 and $5.2 million in Q1 2025.